GSK Probes Staff Bribery Of China Doctors As U.S. Widens Own Probe
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline is conducting its own probe of allegations sales representatives routinely bribed China physicians to prescribe its drug, aside from its internal problems with its research-and-development unit in the country.